Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 8
pubmed:dateCreated
2011-8-15
pubmed:abstractText
Morphine is endogenously synthesized in the central nervous system and endogenous dopamine is thought to be necessary for endogenous morphine formation. As Parkinson's disease results from the loss of dopamine and is associated with central pain, we considered how endogenous morphine is regulated in the untreated and l-DOPA-treated parkinsonian brain. However, as the cellular origin and overall distribution of endogenous morphine remains obscure in the pathological adult brain, we first characterized the distribution of endogenous morphine-like compound immunoreactive cells in the rat striatum. We then studied changes in the endogenous morphine-like compound immunoreactivity of medium spiny neurons in normal, Parkinson's disease-like and l-DOPA-treated Parkinson's disease-like conditions in experimental (rat and monkey) and human Parkinson's disease. Our results reveal an unexpected dramatic upregulation of neuronal endogenous morphine-like compound immunoreactivity and levels in experimental and human Parkinson's disease, only partially normalized by l-DOPA treatment. Our data suggest that endogenous morphine formation is more complex than originally proposed and that the parkinsonian brain experiences a dramatic upregulation of endogenous morphine immunoreactivity. The functional consequences of such endogenous morphine upregulation are as yet unknown, but based upon the current knowledge of morphine signalling, we hypothesize that it is involved in fatigue, depression and pain symptoms experienced by patients with Parkinson's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-4-phenyl-1,2,3,6-tetrahydro..., http://linkedlifedata.com/resource/pubmed/chemical/Choline O-Acetyltransferase, http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agents, http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Plasma Membrane Transport..., http://linkedlifedata.com/resource/pubmed/chemical/Dopamine and cAMP-Regulated..., http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glial Fibrillary Acidic Protein, http://linkedlifedata.com/resource/pubmed/chemical/Glutamate Decarboxylase, http://linkedlifedata.com/resource/pubmed/chemical/Levodopa, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Organic Chemicals, http://linkedlifedata.com/resource/pubmed/chemical/Oxidopamine, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2, http://linkedlifedata.com/resource/pubmed/chemical/S-100 calcium-binding protein beta..., http://linkedlifedata.com/resource/pubmed/chemical/S100 Proteins, http://linkedlifedata.com/resource/pubmed/chemical/alpha-Methyltyrosine, http://linkedlifedata.com/resource/pubmed/chemical/morphine-like compounds...
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1460-2156
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
134
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2321-38
pubmed:meshHeading
pubmed-meshheading:21742735-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, pubmed-meshheading:21742735-Aged, pubmed-meshheading:21742735-Analysis of Variance, pubmed-meshheading:21742735-Animals, pubmed-meshheading:21742735-Brain, pubmed-meshheading:21742735-Choline O-Acetyltransferase, pubmed-meshheading:21742735-Chromatography, High Pressure Liquid, pubmed-meshheading:21742735-Dendrites, pubmed-meshheading:21742735-Disease Models, Animal, pubmed-meshheading:21742735-Dopamine, pubmed-meshheading:21742735-Dopamine Agents, pubmed-meshheading:21742735-Dopamine Plasma Membrane Transport Proteins, pubmed-meshheading:21742735-Dopamine and cAMP-Regulated Phosphoprotein 32, pubmed-meshheading:21742735-Enzyme Inhibitors, pubmed-meshheading:21742735-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:21742735-Female, pubmed-meshheading:21742735-Functional Laterality, pubmed-meshheading:21742735-Gene Expression Regulation, pubmed-meshheading:21742735-Glial Fibrillary Acidic Protein, pubmed-meshheading:21742735-Glutamate Decarboxylase, pubmed-meshheading:21742735-Humans, pubmed-meshheading:21742735-Levodopa, pubmed-meshheading:21742735-Macaca fascicularis, pubmed-meshheading:21742735-Male, pubmed-meshheading:21742735-Medial Forebrain Bundle, pubmed-meshheading:21742735-Mice, pubmed-meshheading:21742735-Mice, Inbred C57BL, pubmed-meshheading:21742735-Mice, Transgenic, pubmed-meshheading:21742735-Microscopy, Immunoelectron, pubmed-meshheading:21742735-Middle Aged, pubmed-meshheading:21742735-Nerve Growth Factors, pubmed-meshheading:21742735-Organic Chemicals, pubmed-meshheading:21742735-Oxidopamine, pubmed-meshheading:21742735-Parkinsonian Disorders, pubmed-meshheading:21742735-Postmortem Changes, pubmed-meshheading:21742735-Rats, pubmed-meshheading:21742735-Rats, Sprague-Dawley, pubmed-meshheading:21742735-Receptors, Dopamine D2, pubmed-meshheading:21742735-S100 Proteins, pubmed-meshheading:21742735-Tandem Mass Spectrometry, pubmed-meshheading:21742735-alpha-Methyltyrosine
pubmed:year
2011
pubmed:articleTitle
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
pubmed:affiliation
University of Bordeaux, Institut des Maladies Neurodegeneratives, Bordeaux, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't